Laura Prendergast
Stock Analyst at Stifel
(4.82)
# 106
Out of 5,154 analysts
17
Total ratings
56.25%
Success rate
79.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals | Initiates: Buy | $48 | $21.55 | +122.74% | 1 | Feb 11, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiates: Buy | $23 | $10.42 | +120.73% | 1 | Feb 11, 2026 | |
| RVMD Revolution Medicines | Maintains: Buy | $85 → $170 | $98.40 | +72.76% | 4 | Jan 22, 2026 | |
| TNGX Tango Therapeutics | Initiates: Buy | $15 | $16.95 | -11.50% | 1 | Dec 4, 2025 | |
| FHTX Foghorn Therapeutics | Initiates: Buy | $12 | $5.78 | +107.61% | 1 | Dec 4, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $99.41 | +35.80% | 2 | Nov 17, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Buy | $8 | $2.15 | +272.09% | 2 | Oct 16, 2025 | |
| ERAS Erasca | Initiates: Buy | $4 | $15.47 | -74.14% | 2 | Oct 16, 2025 | |
| COGT Cogent Biosciences | Initiates: Hold | $16 | $37.08 | -56.85% | 1 | Oct 16, 2025 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.50 | +540.00% | 2 | Aug 14, 2024 |
Olema Pharmaceuticals
Feb 11, 2026
Initiates: Buy
Price Target: $48
Current: $21.55
Upside: +122.74%
BridgeBio Oncology Therapeutics
Feb 11, 2026
Initiates: Buy
Price Target: $23
Current: $10.42
Upside: +120.73%
Revolution Medicines
Jan 22, 2026
Maintains: Buy
Price Target: $85 → $170
Current: $98.40
Upside: +72.76%
Tango Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $15
Current: $16.95
Upside: -11.50%
Foghorn Therapeutics
Dec 4, 2025
Initiates: Buy
Price Target: $12
Current: $5.78
Upside: +107.61%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $115 → $135
Current: $99.41
Upside: +35.80%
Black Diamond Therapeutics
Oct 16, 2025
Reinstates: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Erasca
Oct 16, 2025
Initiates: Buy
Price Target: $4
Current: $15.47
Upside: -74.14%
Cogent Biosciences
Oct 16, 2025
Initiates: Hold
Price Target: $16
Current: $37.08
Upside: -56.85%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.50
Upside: +540.00%